The α7 nicotinic acetylcholine receptor on fibroblast‐like synoviocytes and in synovial tissue from rheumatoid arthritis patients: A possible role for a key neurotransmitter in synovial inflammation
Marjolein A. van Maanen(Amsterdam UMC Location University of Amsterdam), Paul P. Tak(Celldex Therapeutics (United States)), David F. Fischer(University Memory and Aging Center), Esmerij P. van der Zanden(Amsterdam UMC Location University of Amsterdam), Reginald Brys(Galapagos (Belgium)), Susanne P. Stoof(Wilhelmina Children's Hospital), N. Vandeghinste(Galapagos (Belgium)), Richard A. J. Janssen, Margriet J. Vervoordeldonk(University of Amsterdam), Wouter J. de Jonge(University of Bonn)
Cited by 84
Related Papers
NF-κB: a key role in inflammatory diseases
|Journal of Clinical Investigation|2001|3.9k
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
|Pharmacology & Therapeutics|2007|1.6k
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
|Nature Genetics|2010|1.3k
Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway
|Nature Immunology|2005|1.1k
The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation
|British Journal of Pharmacology|2007|634